De Guzman, Zaira Clarisse O.

AU-FA1-PHA3-1

CLINICAL PHARMACY 2 LABORATORY ANSWER SHEET

Directions: Each student will be assigned 2 case studies (25 points each). Write N/A if the information is
not provided in the case study.

Case 1

Patient Name: Gina Stone

Age: 25-year old Gender: Female
Vital Signs: Temp: 39°C
Height: N/A Weight: N/A
Chief Complaint:
The patient visits the emergency department because of her 3-day history of myalgia, chills, and
fever.

History of Present Illness: Physical Exam/Diagnostic Test:

According to her statement, she experienced Based on physical examination Gina is presents a
a rapid onset of symptoms, including nasal 39°C fever.
congestion and cough associated with chest
pain. She does not have a sore throat but Based on Diagnostic test using Viral Tissue Cell
complains of nausea and vomiting that began Culture, it shows virus is progressive
a few weeks ago and has worsened acutely.
She has been vomiting thrice already this
morning prior to coming to the emergency
department.
Past Medical History: Diagnosis:

She has asthma, hypertension, and high lipid Based on the result of the diagnostic test and the
profile. She also has an appendectomy last symptoms the the patient had, she has Influenza.
year.

Medication History/Allergies: Family and Social History:

N/A Gina's mother has a history of lung cancer, and her

father is a Myocardial infarction patient. Her family
was vaccinated annually.
Treatment Plan:
*First thing that the patient must do is to control the symptoms, to avoid another complications of
the disease.
*Gina must take a rest and stay at home to avoid spreading the infection to another.
*Family support is important too.

Pharmacologic Treatment

Zanamivir
10 mg (2 inhalations) bid for 5 days via inhalation device.

The patient should be monitored daily for resolution of the signs and symptoms. If the symptoms
would not be resolved after 10 days, the patient must visit the physician to test if there is a secondary
bacterial infection.

References:

https://www.cdc.gov/flu/professionals/diagnosis/table-testing-methods.htm

Dipiro, J., Talbert, R.L., Yee, G., Matzke, G., Wells, B., & Posey, L.M. (2016) Pharmacotherapy: A
Pathophysiologic Approach (7th ed.). McGraw-Hill Education

https://www.mims.com/philippines/drug/info/zanamivir?mtype=generic
Case 2

Patient Name: Mr. J

Age: N/A Gender: Male
Vital Signs: N/A
Height: N/A Weight: N/A
Chief Complaint:

The patient went back to the hospital for another check up because he observed bloody sputum, he
was having cough/shortness of breath.

History of Present Illness: Physical Exam/Diagnostic Test:

The patient complains about waking up in the
middle of the night and was sweating for the
past months. He also complains of his
unexplained weight loss.
Based on physical examination, Mr. J presents cough.
Based on the results of the diagnostic test, chest
radiograph, the patient have notable round marking
on his lungs.

Past Medical History: Diagnosis:

He was diagnosed with Community-Acquired Based on the result of the chest radiograph and the
Pneumonia last week. He takes medications symptoms that the patient has, the patient was
for Lupus. diagnosed with tuberculosis.

Medication History/Allergies: Family and Social History:

The patients brothers death was caused by

N/A myocardial infarction. Both of his parents had Type 1
Diabetes Mellitus and both of them passed away.
Treatment Plan:

1. Atleast 6 months is needed for continuous drug treatment. It can last up to 2 to 3 years if resistant
develops.
2. The patient must be isolated upon the course of treatment to avoid spreading of the bacteria.
3. Patient must be informed about the administration of the medications. Patients must be informed
that adherence to medications improves the treatment.
4. Surgery may also be needed.

Pharmacologic Treatment

Pyrazinamide and Ethambutol for 2 months followed by Isoniazid (300 mg daily in adult)
Rifampin (600 mg daily) for the next 4 months.
If the patient responds slowly to the medication should be checked again and have another months of
treatment.

The patient must be observed directly to ensure it's adherence to the medications.

References:

Dipiro, J., Talbert, R.L., Yee, G., Matzke, G., Wells, B., & Posey, L.M. (2016) Pharmacotherapy: A
Pathophysiologic Approach (7th ed.). McGraw-Hill Education

https://err.ersjournals.com/content/25/139/97

https://www.drugs.com/cg/human-immunodeficiency-virus-and-acquired-immune-deficiency-
syndrome.html